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Abstract 
Genetic inactivation of essential genes creates an evolutionary scenario distinct from escape from 
drug inhibition, but the mechanisms of microbe adaptations in such cases remain unknown. Here 
we inactivate E. coli dihydrofolate reductase (DHFR) by introducing D27G,N,F chromosomal 
mutations in a key catalytic residue with subsequent adaptation by serial dilutions. The partial 
reversal G27->C occurred in three evolutionary trajectories. Conversely, in one trajectory for 
D27G and in all trajectories for D27F,N strains adapted to grow at very low supplement folAmix 
concentrations but did not escape entirely from supplement auxotrophy. Major global shifts in 
metabolome and proteome occurred upon DHFR inactivation, which were partially reversed in 
adapted strains.  Loss of function mutations in two genes, thyA and deoB, ensured adaptation to 
low folAmix by rerouting the 2-Deoxy-D-ribose-phosphate metabolism from glycolysis towards 
synthesis of dTMP. Multiple evolutionary pathways of adaptation to low folAmix converge to 
highly accessible yet suboptimal fitness peak.   
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Introduction 
The ability of microorganisms to adapt to different environments is crucial for their long-term 
survival and particularly important in the development of antibiotic resistance. Bacterial 
metabolism is often equipped with alternative pathways specialized in the utilization of diverse 
nutrients, which provides microbes an exceptional ability to thrive in various environments and 
under stress from antibiotic treatment. In addition, multi-layers of regulation that global control of 
cellular functions ensures both robustness, against fast fluctuating conditions, and flexibility, 
through slower transcriptional responses to alternating nutrients(Bennett et al., 2008; Buescher et 
al., 2012; Millard et al., 2017). When important cellular functions are inactivated, e.g. by genetic 
mutations, a severe disruption of cellular networks can occur, which poses a major adaptive 
challenge to cells. Recent studies investigated evolution of E. coli upon inactivation of non-
essential enzymes of carbon metabolism that lead to re-wiring through less efficient pathways 
(Krusemann et al., 2018; Long et al., 2018; McCloskey et al., 2018a, b, c, d). These studies 
highlight a crucial interplay between regulatory responses and imbalances in metabolite 
concentrations resulting from gene knockouts, which can be subsequently corrected by mutations 
elsewhere. Importantly all these studies involved gene-knockout so that adaptation by reversal to 
WT genotype was not possible. 
Less is known about the adaptation mechanisms that follow inactivation of unique cellular 
processes that are deemed indispensable in microbes. The genes that perform such functions, often 
classified as essential, are believed to face higher selective pressure and thus evolve slower (Luo 
et al., 2015). It is thus expected that disruption of essential genes can create a major barrier to the 
adaptability of bacteria. Nevertheless, a comprehensive study involving knock outs of >1000 genes 
classified as essential in yeast has shown that a small percentage of mutants could recover viability 
after laboratory evolution (Liu et al., 2015), revealing that essentiality can, in some cases, be 
overcome through adaptation. Loss of essential biosynthetic genes have also been observed to 
occur naturally, under evolutionary conditions where pathway products are provided externally 
(D'Souza and Kost, 2016), highlighting a context-dependent nature of essentiality.  Nevertheless, 
while adaptation upon inactivation of essential genes in microbes has been demonstrated, its 
mechanisms remain unknown. 
Here we study evolutionary adaptation upon functional inactivation of an essential E. coli enzyme 
dihydrofolate reductase (DHFR). Past efforts to link fitness effects of chromosomal variation in 
the folA locus encoding DHFR and their biophysical effects on DHFR protein allowed us to 
develop an accurate quantitative biophysical model of DHFR fitness landscape (Bershtein et al., 
2015a; Bershtein et al., 2013; Bershtein et al., 2012; Bershtein et al., 2015b; Rodrigues et al., 
2016). The availability of a clear genotype-phenotype relationship makes DHFR a unique model 
to study the dynamics and outcomes of evolution to recover from its inactivation by point 
mutations. In contrast to previous studies that used gene knockouts here we inactivate the 
chromosomal E. coli DHFR by introducing mutations in the folA locus at a key catalytic residue 
in position 27, generating strains that express inactive DHFR protein but are viable only with 
external metabolic compensation, allowing the mutants to adapt to lack of DHFR function by 
decreasing supplement concentration.  The advantage of this approach is that it presents cells with 
an obvious evolutionary “solution” of reverting the mutant back to WT-variant without massive 
rewiring that could lead to potentially lesser fit variants. However, an actual outcome may depend 
on evolutionary dynamics which could revert to WT or other form of active DHFR (higher fitness 
peak) or converge to a potentially more accessible solution of rewiring to a less efficient metabolic 
pathways that do not require DHFR function. Therefore, this setup allows us to assess relative 
roles of height and accessibility of fitness peaks in determining the outcome of evolutionary 
dynamics.  
We show that, depending on starting DHFR variant, partial reversion of DHFR phenotype may 
indeed occur. However, adaptation to low concentration of external metabolites through metabolic 
rewiring is the prevalent evolutionary solution due to the availability of a greater number of 
trajectories leading to consecutive gene inactivation events in two key loci, thyA and deoB. Using 
omics analysis, we observe global perturbations in metabolites and proteins levels occurring due 
to DHFR inactivation and upon adaptation, highlighting a key role of regulatory circuits in 
directing evolution. Finally, we show how adaptation to loss of drug target generates highly 
resistant strains, and that one important evolutionary solution found here, inactivation of thyA 
gene, can be also found in clinical isolates of resistant strains of S. aureus (Chatterjee et al., 2008; 
Kriegeskorte et al., 2014) and H. influenza (Rodriguez-Arce et al., 2017).  
Results 
 DHFR is encoded by the folA gene and is essential for the biosynthesis of purine, pyrimidine and 
glycine. We sought to inactivate folA in E. coli by introducing mutations in the key catalytic residue 
D27 (Figure 1A).  
 
 
Figure 1 – 
Automated 
experimental 
evolution of inactive 
DHFR mutants. A) 
Mutations in key D27 
catalytic residue of 
DHFR were 
introduced in E. coli 
chromosome, 
together with flanking 
antibiotic resistant 
markers, by lambda 
red recombination 
and strains devoid of 
DHFR function were 
selected with 
antibiotics in 
folAmix-containing 
agar plates. B) D27 
mutants are lethal but 
fitness can be partially rescued by metabolic compensation with folAmix. Adaptative changes that 
increase fitness can be counterbalanced by decreasing the concentration of folAmix in the growth 
medium, forcing the cells to evolve without DHFR function. C) Experimental evolution using 
automated liquid handling. Six replicates of cell cultures are placed in the first column of a 96well 
plate and incubated at 30˚C with shaking and the optical density is measured every 30 min. The 
cultures grown until the average OD reaches a threshold (0.3), that was defined to avoid nutrient 
limitation and consequent shift into the stationary phase. At this point cultures are diluted 
simultaneously into the wells of the adjacent column, to a common starting OD (0.01), and the 
cycle is repeated. The growth rate is calculated for every culture and whenever it exceeds a defined 
threshold the amount of folAmix is independently decreased for each culture in the subsequent 
dilution.  
However, such approach poses a methodological challenge since, by definition, the knockout of 
essential genes results in lethality or infertility. However, folA knockout mutants are conditionally 
lethal if grown in a culture medium supplemented with a mixture of metabolites comprising 
thymine, glycine, methionine, inosine and adenine (folAmix) (Howell et al., 1988; Kwon et al., 
2010). We envisaged that inactivated DHFR mutants growing in the presence of folAmix could be 
progressively challenged to adapt to ever decreasing concentrations of this supplement in the 
growth medium (Figure 1B). The next step was to develop a protocol that allowed controllable 
decrease of supplement concentration in growth medium in response to the fitness status of the 
cells. This was achieved by implementing a fully automated serial passaging scheme as depicted 
in Figure 1C-D using a Tecan liquid handling robot. In this setup, the growth rate of replicate 
cultures is monitored by periodic OD readings, and the concentration of folAmix is adjusted 
downward in each serial passage when cultures exceed a defined growth rate threshold. This 
feedback control loop ensures mutant strains are continuously challenged to grow at sub-optimal 
conditions, sustaining a strong selective pressure on the loss of DHFR function. This approach 
combines the medium-throughput capabilities of plate-based serial dilution methods (currently, up 
to 32 independent replicate trajectories can be evolved in parallel), and both real-time monitoring 
of fitness status and control of growth conditions featured in morbidostat setups (Toprak et al., 
2012; Toprak et al., 2013), which allows cells to continuously experience exponential growth and 
sustained selection pressure.  
D27 mutations confer growth defects 
We selected single or double nucleotide base mutations to replace a key catalytic residue Asp 27 
either for Asn, Gly or Phe; the presence of a carboxylate side chain in position 27 is strictly 
conserved among DHFR orthologues. Purified D27 mutant proteins were characterized (Table 1)  
Table 1- In vitro properties of DHFR mutant proteinsa 
 
WT D27F D27N D27G D27C 
kcat (s-1) 1.4×10
1
 4×10
-4
 1×10
-2
 1×10
-2
 2.1×10
0
 
KM (µM) 8.7×10
-1
 1×10
2
 1×10
1
 3×10
1
 8×10
1
 
kcat/KM (s-1 µM-1) 1.6×10
1
 4×10
-6
 7×10
-4
 4×10
-4
 3×10
-2
 
k
cat
/K
M
 relative to WT 1 2×10
-7
 4×10
-5
 3×10
-5
 2×10
-3
 
Ki (nM) 0.94 ND ND ND 1.7×104 
ΔTm (0C) a 0 +7.6 b +1.0 -0.3 -1.5 
bis-ANS 1 1.0 1.2 2.4 1.3 
a Kinetic properties for dihydrofolate reductase catalytic activity (kcat = enzymatic turnover number, KM = 
Michaelis-Menten constant, kcat/KM = catalytic efficiency, Ki = inhibition constant for trimethoprim) and 
protein stability properties (ΔTm = difference in melting temperature of folding with respect to wild type, 
bis-ANS = relative fluorescence from binding of bis-ANS to molten-globule intermediates with respect to 
wild type protein.) 
b from Ref (Tian et al., 2015b) 
and the catalytic activity measurements confirm the lack of significant DHFR function in these 
variants; catalytic efficiencies (kcat/KM) are several orders of magnitude lower than WT. However, 
thermal denaturation data obtained for the D27 mutant proteins indicates that their stability is 
mostly unaffected (or even significantly increased in the case of D27F mutant (Tian et al., 2015b)) 
showing that, despite the lack of catalytic activity, these proteins retain the ability to fully fold. 
Importantly, this provides a pathway for restoration of DHFR function over the course of 
evolution, either by revertant mutations at the D27 locus or, potentially, compensatory mutations 
elsewhere in the protein. D27 mutant strains were generated by lambda red recombination 
(Bershtein et al., 2012) and plated in folAmix-containing agar media, however, growth was only 
visible after 48h and the colonies formed were miniscule. When DHFR function was assayed in 
cell lysates of D27 mutant strains, no DHFR activity could be detected, confirming that these 
mutations inactivate DHFR.  As expected, growth experiments showed that D27 mutants grow 
only at high concentrations of folAmix (Figure 2).  
 
 
 
Figure 2 – D27 mutants require 
folAmix to grow. A) The growth rates 
of each D27 mutant and wild type 
were measured at various dilutions of 
folAmix, with respect to initial 
composition (adenine 20 µg/mL, 
inosine 80 µg/mL, thymine 200 
µg/mL, methionine 20 µg/mL and 
glycine 20 µg/mL). Cultures were 
grown in M9-minimal medium at 
30˚C, and absorbance was monitored 
at 600nm. B) Comparison of representative growth curves of wild type and D27F mutant obtained 
in the presence of 1x folAmix  
Interestingly, the D27G mutant shows slightly better growth at lower concentrations of folAmix 
than D27F and D27N. Given that the catalytic efficiency of D27G and D27N mutants is 
comparable, and extremely low, it is very likely that the difference in growth originates from a 
potential acquisition of a slightly advantageous mutation elsewhere upon genetic manipulation to 
introduce D27G mutation in the folA locus (see Discussion). We tested D27 mutants for growth 
in the presence of individual components of folAmix and their different combinations and found 
that only thymine was essential, although growth with thymine alone is slower compared to growth 
with all folAmix components (Supplementary Figure S1).  The growth rates measured for all D27 
mutants at high folAmix fall in the range 70-80% of WT and lag times were typically 1.5-2 fold 
longer (Figure 2 B). Overall, weaker growth and small colony phenotype show that D27 mutants 
are severely compromised even in presence of folAmix.  Using the evolutionary scheme described 
previously, we allowed six replicates of each mutant strain to evolve in parallel for about 50 days.  
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Evolution of D27G mutant 
Cultures of D27G mutant strains were first grown in the presence of folAmix diluted  0.1 fold with 
respect to the initially defined folAmix composition. Throughout the course of the experiment the 
concentration of supplement mixture further decreased, as imposed by the feed-back control loop, 
in response to increasing fitness of the mutant strains (Figure 3A).  
 
Figure 3- Phenotype-
reverting G27C 
mutation emerges 
upon evolution of 
D27G strain. A) 
Evolutionary profiles 
of the six trajectories 
in D27G adaptation 
showing the time 
dependent changes in 
folAmix concentration 
necessary to sustain 
growth. Each 
trajectory is colored 
according to its 
position in the column 
of the 96-well plate, as represented in the scheme (C = wells with growth medium only). B) 
Evolved D27G strain does not require folAmix to grow. The growth rates determined at different 
concentrations of folAmix are compared for wild type, naïve and evolved D27G strains. Data are 
represented as mean ± SD. C) Biophysical properties determined in vitro for the D27C DHFR 
were used to predict growth rate based on the DHFR fitness(Rodrigues et al., 2016). The 
resulting prediction (30% of the wild type value) is in fair agreement with the experimental value 
measured for a BW25113 strain in which D27C mutation was introduced in the wild type folA 
gene (D27C reconstituted). D) Comparison of growth rates of wild type, evolved D27G and 
reconstituted D27C strain. E) Dose-dependent growth inhibition by trimethoprim determined for 
wild type and reconstituted D27C mutant. Solid lines are fits with logistic equation, from which 
IC50 was determined to be 0.7 ± 0.1 µg/mL for wild type and 77 ± 6 µg/mL for D27C mutant.  
The change in folA mix concentration over time reflects the effect of adaptation. Three trajectories 
(1,3 and 6) stand out by reaching the ability to grow in the complete absence of folAmix. 
Trajectories 2 and 5 reached a point where growth dropped below detection limit, and ultimately 
could not be recovered, whereas trajectory 4 had adapted to grow at low concentrations of folAmix. 
We hypothesized that mutations in folA locus could have restored DHFR activity in the cultures 
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where reversion of phenotype was observed. Accordingly, Sanger sequencing analysis of this 
region revealed that in all these three trajectories residue Gly27 had mutated to cysteine. This 
finding was surprising because alignment of multiple known DHFR sequences shows that cysteine 
does not occur naturally in position 27; only aspartate or glutamate are observed in this locus. To 
assess whether Cys27 mutant is functional, this variant was purified and characterized in vitro, and 
its catalytic properties are compared with wild type and other mutants in Table 1. Although 
stability-wise D27C mutant is similar to wild type protein, it shows much weaker catalytic 
efficiency, mostly in terms of  retaining only about 0.1% kcat/KM of wild type. To assess if this 
residual catalytic function is sufficient to explain the reversion of phenotype in the evolved strain 
we first predicted fitness based on a previously established model (Rodrigues et al., 2016). Taking 
as input the vitro biophysical properties of purified D27C mutant, namely kcat/KM and bis-ANS 
fluorescence values, the model predicts a growth rate of about 30% of the wild type strain. To 
check the validity of this prediction, the mutation D27C was reconstituted in the wild type 
background by lambda red recombination and cells were plated in folAmix-containing agar plates 
to lift any selective pressure for DHFR activity. This strain was able to grow in the absence of 
folAmix supplementation, and the measured growth rate was 85% of the wild type, which is in fair 
agreement with the in vitro-based prediction which does not take into account a possibility of 
upregulation in response to DHFR deficiency (Bershtein et al., 2015a)  (see Supporting 
Information for discussion) (Figure 3B-D). This analysis shows that D27C mutation alone explains 
most fitness recovery of the evolved strains. Of note is also the fact that significant loss in catalytic 
efficiency in D27C mutant pays-off with a dramatic 4 orders of magnitude increase in the 
inhibition constant for trimethoprim. (Figure 3E) This is in line with previous observations that 
active site mutations compromise catalytic function but also disrupt pocket interactions with the 
drug, resulting in high levels of resistance (Bader et al., 2006; Rodrigues et al., 2016). 
Evolution of D27F and D27N strains
 
Figure 4 – D27F and D27N mutant evolved to grow at low folAmix concentrations. 
Evolutionary profiles of each trajectory in A) D27F and B) D27N adaptation to loss of DHFR 
function. C) Comparison of growth dependence on folAmix concentration determined for wild 
type, both naïve and evolved D27F and evolved D27N strains, see also Figures S1 and S2. Data 
are represented as mean ± SD. 
MK
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.0 1.0x10-41.0x10-31.0x10-21.0x10-11.0x100
0.0
0.1
0.2
0.3
0.4
 WT
 D27F
 Evolved D27F
 Evolved D27N
G
ro
w
th
 ra
te
 (h
-1
)
FolA mix (fold)
0 10 20 30 40 50
0.00E+000
1E-4
1E-3
0.01
0.1
0 20 40 60 80 100 120 140 160 180
 F
ol
A m
ix
 (f
ol
d 
co
nc
en
tra
tio
n)
Time (days)
Approx. generations
0 10 20 30 40 50
0.00E+000
1E-4
1E-3
0.01
0.1
0 20 40 60 80 100 120 140
 F
ol
A m
ix
 (f
ol
d 
co
nc
en
tra
tio
n)
Time (days)
Approx. generationsA B C
C
1
2
3
4
5
6
C
C
1
2
3
4
5
6
C
Evolutionary trajectories of D27N and D27F mutants represented in Figure 4 A-B show a marked 
decrease in folAmix necessary to sustain growth, reaching concentrations nearly three orders of 
magnitude lower than initially required for naïve strains. Adaptation to grow at low folAmix 
concentrations was verified by showing that growth curves of individual colonies isolated from 
evolved strains are similar to the ones obtained in evolutionary dynamics (Figure 4C). However, 
these strains cannot grow in the complete absence of folAmix. This result indicates that, unlike 
some trajectories in D27G evolution, adaptation of D27N and D27F strains did not involve 
reversion of the folA- phenotype. Accordingly, no mutations were found in folA locus in evolved 
D27N and D27F strains. Other mechanisms must therefore be responsible for the ability to grow 
at low folAmix concentrations. The growth rate of the evolved strain measured at high 
concentrations of folAmix reached values comparable to wild type, showing a clear fitness 
increase with respect to naïve strain. However, at lower concentrations of folAmix the growth rate 
of evolved strain becomes markedly reduced to nearly half of the wild type value and appears to 
plateau in an intermediate range to folAmix concentration. We observed a similar plateau when 
growth was measured at different concentrations of thymine alone (Supplementary Figure S1), 
from which we concluded that at low folAmix concentrations only thymine is being essential to 
sustain growth whereas other components are probably too diluted to have a positive impact in 
fitness. We also evaluated sensitivity to trimethoprim for both naïve and evolved D27F strains. 
Not surprisingly, in the absence of a functional DHFR and in the presence of folAmix D27F mutant 
strains are extremely resistant to trimethoprim (Supplementary Figure S2A). We noted, however, 
that while no decrease in growth was evident in naïve D27F strain up to 1000 µg/mL, the growth 
rate of the evolved strain dropped abruptly above 500 µg/mL trimethoprim, suggesting that the 
drug is acting on an unknown target in the cell which is essential in the evolved but not the parent 
strain. We then tested how the resistance of evolved D27F strain would compare with wild type at 
very low concentrations folAmix (Supplementary Figure S2B). We found that in those conditions 
IC50 for the wild type is similar to that measured in the absence of supplement, yet the evolved 
D27F still shows an extremely high resistance to trimethoprim (IC50=656±78 µg/mL). 
D27 mutation causes major metabolic and proteomic changes. 
The previous observation that D27 mutant strains show severe growth defects suggests that DHFR 
inactivation imposes considerable homeostatic imbalance. We focused on the strain D27F to carry 
out a detailed characterization of the systems-level effects of DHFR inactivation. To that end we 
carried out high throughput proteomics analysis of D27F mutant strains using LC/MS TMT 
approach as described earlier (Bershtein et al., 2015a). The method based on differential labeling 
provides abundances of proteins in the proteome relative to a reference strain which in our case 
was WT (Bershtein et al., 2015a). We computed Z-scores of the log of relative (to wild type as 
reference) abundance according to the following equation: 
, eq. 1 
/ /
/
/
strain ref strain ref
istrain ref
i strain ref
Y
Y Y
z
s
-
=
  
where index i refers to gene,  where and are the gene i 
abundances obtained for the mutant and reference (wild type) strains, respectively,  
denotes a quantity  averaged over all genes for a given strain, and is the standard 
deviation of .  Then, we performed a Student t-test to determine which groups of genes 
had statistically significant variation of protein levels in naïve D27F strain, with respect to wild 
type, following the functional and regulatory classification of genes into groups by Sangurdekar 
et al (Sangurdekar et al., 2011). Numerous processes were significantly altered, reflecting broad 
genome-wide effects of DHFR inactivation (Supplementary Figure S3). Several processes were 
downregulated in naïve D27F strain, from energy metabolism (aerobic respiration, TCA cycle), to 
the metabolism of nitrogen, several amino acids, pyrimidines and lipopolysaccharides. On the 
other end, we found significant upregulation of stress responses, peptidoglycan recycling and 
salvage of guanine and xanthine. We then performed both targeted and untargeted metabolomic 
analysis of naïve D27F mutant strain and wild type (see experimental details) to characterize 
significant changes at the level of metabolites. Likewise, Z-scores for metabolite levels were 
computed for naïve D27F mutant, with respect to wild type. The metabolites with the highest 
absolute Z-scores  (>1.96) were selected for an enrichment test using MBRole online software 
(Lopez-Ibanez et al., 2016) to identify pathways in which altered metabolites are overrepresented. 
The analysis revealed that the metabolism of purines, pyrimidines, beta-alanine, histidine and 
sulfur were the most significantly changed in naïve D27F mutant comparatively to wild type 
(Supplementary Figure S4). A detailed scheme representing the changes in metabolites and 
proteins levels of nucleotide synthesis pathways is shown in Figure 5A.  
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 Figure 5 – D27 mutation causes major metabolic and proteomic changes. A) Schematic 
representation of purine and pyrimidine biosynthetic pathways depicting changes in the levels of 
metabolites and proteins for the naïve D27F mutant (Z-scores, relative to wild type). Metabolites 
are represented by circles and arrows represent enzymatic reactions color-coded by the levels of 
associated proteins (see also Figures S3 and S4). Light gray shading indicates that no data is 
available. Metabolites that are downstream of the enzymatic reactions requiring reduced folates 
(ThyA, PurH and PurT) are strongly depleted in naïve D27F mutant, whereas those metabolites 
immediately upstream to those reactions are increased in respect to wild type. B) Proteomics 
changes upon evolution partially revert the effect of DHFR inactivation (see also Figures S5 and 
S6). Comparison of the changes in protein levels obtained for evolved D27F, D27N and D27G 
strains (Z-scores, relative to naïve D27F) with those measured for naïve D27F (Z-scores, relative 
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D27F D27N D27G
to wild type). C) Comparison of the changes in metabolite levels measured for evolved D27F strain 
(Z-scores, relative to naïve D27F) with those measured for naïve D27F (Z-scores, relative with 
wild type). D-E) Inhibitory or stimulatory effect of purine/pyrimidine metabolites supplementation 
on the growth of the naïve D27F strain is attenuated in the evolved D27F strain. The intracellular 
levels of various purine and pyrimidine species including bases, (deoxy)nucleosides and 
(deoxy)nucleotides, were determined by targeted metabolomics for naïve (black circles) and 
evolved (red circles) D27F strains, represented as Z-scores relative to wild type (see also 
supplemental Figure S5). The effect of supplementation with individual metabolites on growth was 
determined by growth measurements of naïve and evolved D27F mutant strains in M9 minimal 
medium supplemented by 1.6 mM thymine in combination with one of each tested metabolites (1 
mM final concentration). Relative growth represents the maximum OD obtained for each 
metabolite normalized to the value measured in the presence of thymine alone. Although most 
purine metabolites are strongly depleted in naïve D27F mutant, supplementation of the culture 
medium with these compounds has a strong inhibitory effect on growth. Contrastingly, pyrimidines 
have a stimulatory effect on growth. In evolved D27F strain, the supplementation with purines and 
pyrimidines has only a marginal effect on growth 
Not surprisingly, we observe build-up of metabolites upstream the reactions that require reduced 
folate cofactors (purT, purH, and thyA), whereas metabolites downstream of those reactions are 
found to be strongly depleted.  
Evolved D27 strains partially revert the omics effects of DHFR inactivation 
Next, we carried out same LC/MS TMT proteomics analysis of evolved strains (D27F, D27N and 
D27G) to help identify systems-level changes emerging from adaptation to lack of DHFR function. 
To get a glimpse of global proteomics changes we applied PCA analysis which revealed that both 
wild type and evolved D27G occupy the same quadrant in the space of two principal components, 
whereas D27 mutants that are folAmix dependent cluster more closely in another quadrant 
(Supplementary Figure S5). We then computed the Z-scores for the proteomic changes in evolved 
strains with respect to naïve D27F (ZD27_evo/D27F_naïve), to assess the effect of evolution on the 
proteomic levels, and plotted these values against ZD27F_naïve/WT to compare with the initial changes 
caused by D27F mutation. A clear anticorrelation was observed for all mutants (Figure 5B), being 
the strongest for evolved D27G strain. These results indicate that adaptation leads to proteomic 
changes that generally oppose the immediate effects caused by DHFR inactivation. In the case of 
D27G, the strong global proteomic shift towards wild type levels is somewhat expected since in 
the evolved strain, the DHFR activity is partly restored by G27->C mutation. To better characterize 
the proteomic changes that were specific to evolution of folAmix dependence we performed a 
functional and regulatory classification analysis to identify which groups of genes were 
significantly altered in both evolved D27F and D27N, with respect to naïve D27F strains. We 
found an upregulation of genes involved in glycolysis, fermentation, sugar alcohol degradation 
and response to low pH, suggesting a metabolic shift towards mixed acid fermentation as a result 
of adaptation. On the other hand, the processes of DNA restriction/methylation and D-ribose 
uptake were significantly down regulated with respect to naïve D27F in both evolved D27F and 
D27N strains. Next, we focused on evolved D27F strain to perform a detailed metabolomic 
analysis and characterize the changes occurring at the level of metabolites. We computed Z-scores 
for metabolite changes with respect to naïve D27F (ZD27_evo/D27F_naïve) and we found significant 
anticorrelation with Z-scores obtained for naïve D27F (ZD27F_naïve/WT) (Figure 5C), indicating that 
metabolite concentrations in evolved strain generally change to partially recover wild type levels, 
as observed with proteomics. We found that the pathways significantly enriched in metabolites 
with the highest ZD27_evo/D27F_naïve scores (>1.96)  in evolved D27F were the same as those that had 
the most significant changes in naïve D27F, with respect to wild type (Supplementary Figure S6). 
Overall these results show that adaptation to low folAmix concentrations is accompanied by an 
overall shift in the abundance of metabolites and proteins to partially revert the system-level 
changes that are caused by DHFR inactivation. 
Regulatory responses are altered in evolved D27F strain 
Metabolites of purine and pyrimidine biosynthetic pathways were among the most strongly 
depleted in naïve D27F strain and showed highest increase upon evolution (Supplementary Figure 
S4). We reasoned that these depleted metabolites could be limiting growth of the D27 mutants, 
and that supplementing the culture medium with these metabolites would improve growth. 
Surprisingly, supplementation with purines strongly inhibited growth of the naïve D27F strain, 
whereas pyrimidines addition had a stimulatory effect (Figure 5D, and Supplementary Figure S7). 
The detrimental effect of purine supplementation suggests that drop in purine metabolites in naïve 
D27F was a regulatory response to high levels of the purines supplied by the culture medium. In 
the case of evolved D27F strain, the effect of supplementation of individual nucleotides on growth 
was comparably weaker or non-existent, indicating that the inhibitory/stimulatory effects were 
relaxed upon adaptation. It is possible that the profound metabolic and proteomic changes upon 
DHFR inactivation amount to cells switching their proteomes and metabolomes to a novel stable 
state. In these conditions, the “programmed” responses that are triggered by high external 
concentrations of metabolites might actually worsen the fitness of the cell, instead of providing 
the beneficial advantage that they have evolved for. On the other hand, after evolution, even though 
metabolites and proteins levels are still quite distinct from wild type values, the regulatory network 
appears to be better adapted to that new metabolic state. Adaptation can either result from changes 
in the regulatory network itself, due to mutations in regulatory genes, or from re-wiring of 
metabolic pathways that establish a different metabolic state for which existing regulatory 
networks provide more optimal responses. 
Whole genome sequencing 
Whole genome sequence (WGS) analysis was performed to identify the genetic basis for the 
systems-wide changes observed in evolved strains. In addition, to characterize the dynamics of 
mutation fixation, individual colonies from intermediate evolutionary time points of a selected 
D27F trajectory were also sequenced.  
 
 
Figure 6 – Loss of 
function mutations in two genes, thyA and deoB, lead to adaptation to low folAmix 
concentrations. A)  Mutations identified in naïve and evolved D27 mutant strains. Vertical lines 
identified with NGS represent mutations identified by whole genome sequencing whereas the 
remaining cases were identified by Sanger sequencing. Details are presented for trajectory 2 of 
D27F evolution and include the mutations identified at various passages and the folAmix profile 
obtained for that trajectory. B) Mutations identified in the most relevant genes. C) Mapping thyA, 
deoB and folA mutations found among evolved strains from all trajectories (1 to 6) of each D27 
mutant. Colored dots represent the presence of mutations, whereas gray dots represent genes that 
were not mutated in evolved strains. Trajectories that ceased growth prior to the end of the 
experiment were not sequenced (gray squares). D-E) Expression of wild type DeoB and ThyA in 
evolved D27F strain reverts phenotype to high folAmix requirement. Evolved D27F strain, with 
background mutations deoB p.D10G and thyA 403-410del, was transformed with pTRC-tetR 
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plasmid coding D) wild type or mutant deoB and E) wild type or mutant thyA, under the control 
of tetR repressor. Evolved D27F strain without plasmid is also represented as control. Cells were 
grown in M9 minimal medium and growth rates were measured from periodic OD measurements. 
Data are represented as mean ± SD. * P<0.01, ** P<0.001. F) Inactivation in deoB gene prevents 
2-deoxy-D-ribose-1-phosphate from being diverted into energy production via glycolysis and 
tricarboxylic acid cycle. Changes in the levels of metabolites (depicted as circles) and proteins 
(depicted as arrows) in the evolved D27F strain (Z-scores, relative to naïve D27F mutant) are 
represented. The genes involved in 2-deoxy-D-ribose-1-phosphate degradation are marginally 
increased in evolved D27F, with respect to naïve strain (average Z-score = 0.445, P=0.0817, see 
Figure S6). However, deoB inactivation saves 2-deoxy-D-ribose-1-phospahte that is required in 
dTMP production, instead of being utilized for energy production in glycolysis, which is 
significantly upregulated in evolved D27F, with respect to naïve D27F (average Z-score= 0.593, 
P= 0.015 
Figure 6 A-B summarizes the WGS results obtained for evolved and naïve strains from each D27 
mutant. We found that D27N and D27G strains, but not D27F, had additional background 
mutations that must have been acquired prior to starting the evolution experiments; although all 
D27 strains were constructed from the same parent wild type strain, we could not prevent the 
appearance of mutations at any given stage prior to the evolution experiments. It is possible that 
these mutations may provide some fitness advantage with respect to “pure” D27F strain (see below 
and discussion). Comparison between evolved and naïve D27G strains reveals that no other 
mutation was fixed upon evolution besides the one nucleotide change at the D27 locus of the folA 
gene, corresponding to the Gly->Cys substitution described earlier. This is fully consistent with 
the earlier conclusion that D27C mutation alone explains the fitness recovery observed in D27G 
evolution. From the analysis of evolved D27F and D27N we can identify two common hotspots 
for mutations, the genes thyA and deoB, encoding thymidylate synthase and phosphopentomutase, 
respectively. For that reason, the sequence of these two loci were determined by Sanger analysis 
for all other trajectories that evolved to grow at low folAmix concentrations, including trajectory 
4 in D27G evolution. Strikingly, in a total of 12 trajectories all were found to have mutations in 
thyA and 11 had deoB mutated (Figure 6C). We noted as well that evolved D27F strains also carried 
mutations in other genes, crr (7bp deletion), rpe and yhdH (4bp deletion), however, these were not 
observed among other trajectories indicating that these are most likely either random passenger 
mutations or provide only marginal advantage on a specific genetic background. On the other hand, 
the occurrence of deletions in both thyA and deoB strongly implies that functional inactivation of 
these gene products arises as a main mechanism of adaptation to the lack of DHFR function. We 
reasoned that complementation with either thymidylate synthase or phosphopentomutase should 
create a significant fitness disadvantage to the evolved cells, which can be reverted if these 
enzymes become inactivated. To verify this prediction, we transformed evolved D27F strains with 
plasmids expressing either wild type thyA or deoB and compared the ensuing growth rates of these 
strains with transformants carrying the same plasmids expressing inactivated thyA and deoB, 
respectively. Expression of functional ThyA and especially DeoB were found to be highly 
deleterious at low folAmix concentrations, as shown Figure 6 D-E, whereas no significant change 
in growth was observed upon expressing inactive mutants. The gene deoB is part of an operon 
responsible for deoxyribose degradation, that includes deoA, deoC, and deoD, which is under the 
control of 2-deoxyribose-5-phosphate-inducible deoR repressor (Hammer-Jespersen and Munch-
Ptersen, 1975). DeoB catalyzes the interconversion of 2-Deoxy-D-ribose-1-phosphate and 2-
Deoxy-D-ribose-5-phosphate, and, while the former is necessary for synthesis of dTMP from 
thymine by DeoA, the latter can be further degraded in glycolysis, through conversion into 
acetaldehyde and D-glyceraldehyde 3-phosphate by DeoC (Figure 6F). Repression of deo operon 
might be deleterious because expression of DeoA is essential for thymine uptake, however co-
expressing high levels of DeoB and DeoC can also have a negative effect by directing 2-deoxy-D-
ribose-1-phosphate for degradation. Therefore, inactivating deoB or deoC is an “economy” 
solution preventing key metabolite in thymine uptake to be  wasted in energy production, allowing 
cells to efficiently use small amounts of thymine available from media supplement for nucleotide 
synthesis (Dale and Greenberg, 1972). It is also clear that, since we found no mutations in 
regulatory genes, the origin of the attenuation of the nucleotide-mediated inhibitory/stimulatory 
effects observed in evolved D27F strain are most likely due to global changes in protein/metabolite 
concentrations. 
Overall, these results show that two key loss of function mutations alone are responsible for the 
partial adaptation of D27F to loss of DHFR activity and result in significant metabolic, proteomic 
and regulatory shifts observed in the evolved strains.  
Discussion 
In this study we set to explore the evolutionary mechanisms that follow inactivation of the essential 
gene that encodes DHFR. Such scenario is akin to antibiotic-mediated target inhibition, but distinct 
in several aspects. When treated with DHFR inhibitor trimethoprim, bacterial cells recurrently 
acquire resistance by mutations that decrease drug binding affinity and/or enhance target 
abundance levels (Toprak et al., 2012). In contrast, genetic inactivation of DHFR at the conditions 
studied here constrains evolution towards solutions that appear to be mutually exclusive, either 
restoration of DHFR catalytic activity or adaptation to lack of DHFR function. Interestingly, both 
evolutionary outcomes were observed. While D27F, D27N and one trajectory in D27G 
convergently adapted to lack of DHFR function, other trajectories in D27G mutant reached 
reversion from thymine auxothrophy phenotype. It is important to address the possible reasons for 
the observed outcome. A major confounding factor could be the presence of background mutations 
in some of these strains. We note the potential role of the mutation in upp gene present in D27G 
strain. This gene encodes the enzyme uracil phosphoribosyltransferase that participates in 
pyrimidine salvage pathway and, quite strikingly, appeared consistently depleted in proteomics 
analysis of all D27 mutants. The slightly higher fitness previously noted for D27G (Figure 2A) 
could be due some beneficial effect of the upp and/or ymfD mutation. Conceivably, such small 
difference in fitness could be a key factor determining the outcome of evolution, but further 
experiments are needed to test this hypothesis. The codon structure of each mutant studied here 
and bias in the frequency of each mutation type can also affect the likelihood that phenotype-
reverting mutations may arise. We note that the nearest accessible high-fitness Asp/Glu codon for 
D27F mutant is two nucleotide substitutions away, whereas both D27G and D27N could be 
rescued by a single G->A or A->G transition, respectively. Only D27G was found to revert, 
however, not to wild type codon, but to a less catalytically efficient cysteine residue caused a G-
>T transversion. In this respect, it is rather surprising that D27C mutation was fixed in 3 
independent trajectories when transversions are generally regarded to be less likely than 
transitions.  Another important factor in determining the fate of D27 mutant evolution appears to 
be the early fixation of thyA inactivating mutations. Thymidylate synthase is the only known 
enzyme in E. coli able to synthetize dTMP de novo from dUMP, and inactivation of thyA inevitably 
commits the cell to thymine auxothropy; reversion of DHFR function on the thyA- background is 
not expected to change this phenotype, as it is known that folA+ thyA- strains are thymine-
dependent (Bertino and Stacey, 1966). Competition between DHFR reversion and thyA 
inactivation thus appears to be decisive in determining the evolutionary solution. However, since 
inactivation of a gene can be achieved by multiple ways, there is an incomparably greater number 
of accessible evolutionary trajectories leading to thyA knockout when compared with the very 
limited available mutational routes that restore DHFR function.  
Upon thyA inactivation, the only available route for dTMP synthesis involves DeoA-catalyzed 
formation of thymidine from thymine and 2-deoxy-D-ribose-1-phosphate (Figure 6F). However, 
DeoA is part of the deo operon that is induced by high levels of 2-deoxy-D-ribose-5-phosphate. 
This regulatory scheme allows cells to recycle excess metabolites into energy production. 
However, on the background of thyA inactivation, the co-expression of deo operon proteins creates 
simultaneously a solution and a problem for the uptake of thymine. Now DeoA becomes an 
essential protein, but its function is opposed by the roles of DeoC and DeoB which divert 2-Deoxy-
D-ribose-1-phosphate into degradation via the glycolysis pathway. The evolutionary solution 
found in D27 strains converged to the inactivation of a single gene of the operon, deoB, an event 
that is sufficient to block the degradation pathway and yet the regulatory structure is retained. This 
critical example illustrates the role of regulatory circuits in constraining evolution when disruption 
of an essential gene forces the system to adopt a metabolic state well beyond normal-operating 
homeostatic boundaries. Understanding these processes is critical for guidance towards new 
strategies for antibiotic resistance prevention. Perhaps not surprisingly, we found that pathways of 
adaptation to genetic inactivation of an antibiotic target provide a route to high levels of resistance. 
Strikingly, mutations in thyA are also known to confer trimethoprim resistance in bacterial clinical 
isolates of S. aureus (Chatterjee et al., 2008; Kriegeskorte et al., 2014) and H. influenza 
(Rodriguez-Arce et al., 2017), which emphasizes the need of laboratory studies of microbial 
adaptation as useful models to tackle serious global threat. 
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STAR Methods 
 
Contact for Reagent and Resource Sharing 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Eugene I. Shakhnovich (shakhnovich@chemistry.harvard.edu). 
Experimental Model and Subject Details 
Construction of D27 mutants 
Inactive D27 mutants were created by lambda-red recombination (Datsenko and Wanner, 2000) 
according to a previously described procedure (Bershtein et al., 2012) with some modifications. 
Briefly, a pKD13 plasmid was modified to contain the entire regulatory and coding sequence of 
folA gene, flanked by two different antibiotic markers (genes encoding kanamycin (kanR) and 
chloramphenicol (cmR) resistances) and approximately 1kb homologous region of both upstream 
and downstream chromosomal genes flanking folA gene (kefC and apaH, respectively). The entire 
cassete was amplified and transformed into BW25113 cells with induced Red helper plasmid 
pKD46, and cells were recovered in SOC medium containing 1x folAmix (adenine 20 ug/mL, 
inosine 80 ug/mL, thymine 200 ug/mL, methionine 20 ug/mL and glycine 20 ug/mL). 
Transformants were plated in agar media containing both antibiotics and folAmix. Correct 
integration of the desired mutations was confirmed by Sanger sequencing of folA gene. Plasmid 
pKD46 was removed by plating cells at 37 °C twice in the absence of antibiotic selection. 
 
Method Details 
Automated experimental evolution 
A liquid handling instrument Tecan Freedom Evo 150 equipped with Magellan plate reader and 
Liconic shaker was used in this work. The experiments were done at 30 ˚C and using M9 minimal 
media supplemented with 2g/L glucose, 34µg/mL chloramphenicol and 50µg/mL kanamycin. The 
general procedure involves up to four 96-well plates that are used for serial dilutions of bacterial 
cultures. Each working plate can carry 8 trajectories that are positioned in a single column. In this 
work we used the first and eight wells in the column with media alone to control for contamination. 
The experiment starts by placing the 200 µL cultures/control in the first column of the 96-well 
plate. All the four plates are incubated in a shaker at 30 ˚C and at every 30 min the OD of each 
plate is determined alternately. The growth rate of each culture is calculated from OD 
measurements over time. To ensure proper comparison, the growth rate was computed only from 
OD values within a specified range (0.1-0.25). When the average OD of the six experimental 
replicates in a plate exceeds a threshold of 0.30, each culture is diluted into the next adjacent 
column by mixing a calculated volume of both culture and fresh medium and folAmix so that the 
initial OD is 0.01 in a total of 200 µL. At this point, the remaining portion of the previous culture 
is mixed with glycerol in an auxiliary plate and subsequent freezed at -80C. The cycle is repeated 
through the entire experiment. At every passage, the growth rate is compared with a threshold 
value (0.16 h-1) and whenever a culture exceeds this value the concentration of folAmix is halved. 
Media and Growth Conditions  
Cell cultures were recovered by inoculating fresh M9 media medium supplemented with 0.2% 
glucose and 1x folAmix with a portion of -80˚C glycerol stocks taken at different passages. After 
recovery for several hours, the cultures were plated in selective agar media containing 1x folAmix 
and incubated at 30˚C. Individual colonies were grown in M9-media+folA mix and stored in 
glycerol at -80˚C for later analysis. Cell cultures grown overnight were diluted in fresh M9 minimal 
media containing 1x folAmix and antibiotics and were grown for additional 4-6 h. Cultures were 
then pelleted by centrifugation and washed 3 times in fresh M9 without folAmix. Microplates 
containing 150 µL of M9 minimal with 0.8g/L glucose, antibiotics, and varying concentrations of 
folAmix were then inoculated with each culture at a starting OD of 0.0005. Growth measurements 
were performed in a Infinite® 200 PRO plate reader for 48h at 30˚C with constant shaking. Growth 
rate values are represented as mean ± SD from at least 3 biological replicates. 
Protein purification and characterization 
D27 mutant fused to C-terminal (6x) His-tag were overexpressed using pFLAG expression vector 
under isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible T7 promoter. The recombinant 
proteins were purified from lysates on Ni-NTA columns (Qiagen) as described 
previously(Rodrigues et al., 2016). DHFR kinetic parameters were derived from the analysis of 
progress-curve kinetics of NADPH oxidation in the presence of dihydrofolate using the software 
Kintek Explorer (Johnson, 2009) as described before(Rodrigues et al., 2016).  
Predicting fitness of D27 mutants 
The fitness of E. coli DHFR mutants can be predicted from in vitro biophysical parameters using 
a simple metabolic model described in an earlier work (Rodrigues et al., 2016). The metabolic flux 
through DHFR reaction in DHFR mutant strains, normalized to wild type, can be approximated 
to: 
      eq. 2 
Where, ,  and are, respectively, the catalytic efficiency, trimethoprim inhibition 
constant and intracellular protein abundance of the mutant or of the wild type, and and  
are, respectively, the concentration of trimethoprim in the culture medium and the ratio of 
intracellular vs extracellular concentrations of trimethoprim, defined previously to be 0.1 
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(Rodrigues et al., 2016). To connect flux to fitness, we first measure the growth rate of wild type 
E. coli cells at various concentrations of DHFR inhibitor trimethoprim. 
Then fitness is plotted against the flux through DHFR reaction calculated at each concentration of 
inhibitor using equation 2, and catalytic parameters determined in vitro (Table 1). Protein 
abundance is determined by measuring the total catalytic activity in cell lysates, as described 
earlier (Rodrigues et al., 2016). Finally, we use equation 3: 
   eq. 3 
to fit the fitness vs Vnorm data points to determine the parameter B, which represents the normalized 
flux at which growth rate is reduced by half. From this equation, the in vitro parameters determined 
for D27 mutants are used in equation 2 and 3 to predict fitness. The protein abundance of D27 
mutants, however, cannot be determined from enzymatic assays in cell lysates, as these are inactive 
variants. Instead, protein abundance was predicted using an inverse relationship with relative bis-
ANS fluorescence of those variants (Bershtein et al., 2013; Rodrigues et al., 2016). In qualitative 
terms, our model accurately predicted that the D27C variant is able to grow in the absence of 
folAmix supplement. However, the measured fitness was somewhat higher than the value 
predicted by the calculations. It is possible that some assumptions are not entirely met. One 
important assumption is that the concentration of DHFR and substrate dihydrofolate are either 
always constant or change only as a function of the flux calculated by equation S1. The latter 
implies that, for every given value of flux, the changes in DHFR and dihydrofolate concentration 
will always be the same, and thus always comparable regardless of what parameters are used as 
input in equation S1. However, this might not be always true. For example, a tight feedback control 
regulates the DHFR promoter activity, in response to the metabolic needs of the cell (Bershtein et 
al., 2015a; Bershtein et al., 2015b). Likewise, a decrease in DHFR catalytic function is also 
expected to result in a considerable level of substrate build up. In these conditions, the magnitude 
of substrate KM for each variant might become more relevant. In our calculations, however, 
substrate saturation is not considered. This may lead to deviations, especially when KM values 
differ significantly, as we find in this work. How much these dynamic processes may differently 
affect the flux through DHFR reaction in each mutant is still to be determined. 
 
 
Effect of deoB and thyA expression 
The genes deoB and thyA and corresponding mutants deoB p.309Stop and thyA 755-762del were 
cloned into a modified pTRC plasmid in which the laqI and promoter region were replaced by the 
tetR repressor gene and promotor region derived from plasmid Plasmid pEM-Cas9HF1-recA56 
(addgene Addgene plasmid # 89962 (Moreb et al., 2017)). Transformed strain cells were grown in 
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M9 minimal media + folAmix, then washed with fresh M9 media without folAmix and plated at 
different concentration of folAmix. Growth rate values are the mean ± SD of at least 3 biological 
replicates.  
Metabolite extraction and LC-MS analysis 
Cultures of mutant strains (naïve and evolved D27F) and wild type (30 mL) were grown in parallel 
in M9 minimal media supplemented with 2 g/L glucose in a 250 mL flask at 30C. At an OD of 
0.2-0.25 the cultures were centrifuged. The volume of culture to be pelleted was calculated so that 
the product OD × volume of cell culture (mL) = 5. The pellet was mixed with 300 µl of 80:20 ratio 
of methanol:water that had been pre-chilled on dry ice. Samples were vortexed and incubated in 
dry ice for 10 min followed by centrifugation at 4˚C for 10 min at maximum speed. The supernatant 
was collected, and the pellet was processed by repeating the procedure. Samples were stored at -
80˚C until analyzed by mass spectrometry. At least three independent biological replicates were 
analyzed for each strain. LC-MS analysis in the positive and negative mode was performed as 
previously described (Bhattacharyya et al., 2016). Retention times of several metabolites of the 
nucleotide biosynthesis pathway were determined from the analysis of pure compounds.  
LC/MS TMT Proteomics 
Cell cultures from isolated colonies were grown at 30˚C in M9 minimal media supplemented with 
0.2% glucose and were collected by centrifugation during mid-exponential phase (OD ~ 0.2-0.25), 
well below saturation due to oxygen limitation (typically at OD>0.8-0.9). Global proteomic 
analysis was performed as described previously (Bershtein et al., 2015a). 
 
Whole-genome sequencing 
Sequencing was performed on isolated colonies on Illumina MiSeq in 2x150 bp paired-end 
configuration (Genewiz, Inc., South Plainfield, NJ). The raw data were processed with the 
DRAGEN pipeline  on default settings, using the E. coli K-12 substr. MG1655 reference genome 
(GenBank accession no.  NC_000913.3). After the alignment completed, structural variations (SV) 
including large INDELs (above 50) were detected using the program Manta(Chen et al., 2016). 
 
 
 
 
Quantification and Statistical Analysis 
Metabolomics data analysis.  
Data analysis was performed using the software packages MzMatch (Scheltema et al., 2011) and 
IDEOM (Creek et al., 2012) for untargeted analysis. For peak assignment in untargeted analysis, 
IDEOM includes both peak m/z values and predicted retention times calculated based on chemical 
descriptors (Creek et al., 2011). A list of 32 experimentally measured retention times was initially 
used to calibrate retention time predictions. The retention time of putatively identified metabolites 
were found to correlate fairly well with the values included in IDEOM (R2=0.73) and published in 
other studies (Pluskal et al., 2010) (Pluskal et al., 2010) (R2=0.88 and R2=0.61, respectively). For 
this reason, additional metabolites from those sources that closely matched IDEOM assignments 
were treated as standards in the identification routine. Following identification, Z-scores with 
respect to wild type (ZD27F_naïve/WT) or to naïve D27F strain (ZD27F_evo/D27F_ naïve) were calculated 
using equation 1. Z-scores determined for each set i of n biological replicates were combined for 
each metabolite met using the expression .  The set of metabolites with highest 
absolute combined Z-scores (>1.96) was selected to perform an overrepresentation (enrichment) 
analysis of categorical annotations using MBrole2.0 (Lopez-Ibanez et al., 2016), using as reference 
the metabolic pathways of E. coli from KEGG database. 
 
Proteomics data analysis 
 
Z-scores were computed using equation 1. For grouping analysis, we used the functional and 
regulatory classification group sets as (Sangurdekar et al., 2011). For each set of genes belonging 
to a group we employed a one-sample t-test which provides the p-value against the null hypothesis 
that the group of genes was drawn from a normal distribution and considered that a given group 
of genes is upregulated or downregulated with respect to a reference if the average of Z-scores of 
that group is positive or negative, respectively. 
 
 
Table S1-Primers list 
tetR_pTRC_for  ACACCATCGAATGATATCGACGTCTTAAGACCCACTTT 
tetR_thyA_rev  CTAAATACTGTTTCATAGATCCGAAGTCCTCTTTAGATC 
tetR_thyA_for  GACTTCGGATCTATGAAACAGTATTTAGAACTGATGC 
tetR_thyA-rev  GACTTCGGATCTATGAAACAGTATTTAGAACTGATGC 
tetR_deoB_for  GACTTCGGATCTATGAAACGTGCATTTATTATGGTGC 
pTRC_deoB_rev  AAAACAGCCAAGCTTTCAGAACATGGCTTTGCCATATTCC 
deoB_pTRC_for  AAAGCCATGTTCTGAAAGCTTGGCTGTTTTGGCGGATGAG 
 deoB_tetR_rev  AAATGCACGTTTCATAGATCCGAAGTCCTCTTTAGATC 
n
met
i
met i
combined
z
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å
CapR-Chrom-
Flanking rev 
TTAGGATGAGGGTTTCGTTTCCGGTTCATC 
PCRseq_KefC_fo
r2 
CTGCTCGGTTTCCTCATCATCAA 
P4_chrom_flankin
g for 
TTTTGTATAGAATTTACGGCTAGCGCCG 
PCRseq_apaH_re
v 
CGTCCCTTTCAGCATCGACATT 
pKD13_post_dow
nsream_for 
CTTATCACTGATCAGTGAATTAATGGCG 
pKD13_post_upst
ream_rev 
GACAATAACCCTGATAAATGCTTCAATAATATTG 
Upstream_capR_f
or 
GAAGAAGGTAAACATACCGGCAACATGGCGGATGAACCGGAAACGAAACCC
TCATCCTAATCATGATCATCGCAGTACTGTTG 
P4downstream_re
v 
AAGGCCGGATAAGACGCGACCGGCGTCGCATCCGGCGCTAGCCGTAAATTC
TATACAAAACTGTCAAACATGAGAATTAATTC 
Ampl_RRfolA_for GTGCCGATCAACGTCTCATTTTCG 
Ampl_RRfolA_rev GCTTCCTCGTGCTTTACGGTATCG 
PCRseq_RRfolA_
rev 
GCCTTCTATCGCCTTCTTGACGA 
D27Fmut_For TTTCTCGCCTGGTTTAAACGCAACACCTTAAATAAAC 
D27Gmut_for GGCCTCGCCTGGTTTAAACGCAACACCTTAAATAAA 
D27Nmut_for AATCTCGCCTGGTTTAAACGCAACACCTTAAATAAAC 
D27_rev GGCAGGCAGGTTCCACGGCATGG 
 
 
Excel Tables  
LC/MS TMT Proteomics Data: Proteomics_data.xlsx  
Sequencing data:  Sequencing_data.xlsx 
Metabolomics data: Metabolomics_data.xlsx 
 
